share_log

Zhejiang Runyang New Material Technology's (SZSE:300920) Earnings Seem To Be Promising

Zhejiang Runyang New Material Technology's (SZSE:300920) Earnings Seem To Be Promising

浙江潤陽新材料科技(深圳證券交易所代碼:300920)的收益似乎令人鼓舞
Simply Wall St ·  05/04 20:35

Shareholders appeared to be happy with Zhejiang Runyang New Material Technology Co., Ltd.'s (SZSE:300920) solid earnings report last week. Looking deeper at the numbers, we found several encouraging factors beyond the headline profit numbers.

股東們似乎對浙江潤陽新材料科技有限公司感到滿意。”s(深圳證券交易所代碼:300920)上週的收益報告穩健。深入研究這些數字,除了總體利潤數字外,我們還發現了幾個令人鼓舞的因素。

earnings-and-revenue-history
SZSE:300920 Earnings and Revenue History May 5th 2024
SZSE: 300920 收益和收入歷史記錄 2024 年 5 月 5 日

The Impact Of Unusual Items On Profit

不尋常物品對利潤的影響

To properly understand Zhejiang Runyang New Material Technology's profit results, we need to consider the CN¥4.2m expense attributed to unusual items. It's never great to see unusual items costing the company profits, but on the upside, things might improve sooner rather than later. When we analysed the vast majority of listed companies worldwide, we found that significant unusual items are often not repeated. And, after all, that's exactly what the accounting terminology implies. Assuming those unusual expenses don't come up again, we'd therefore expect Zhejiang Runyang New Material Technology to produce a higher profit next year, all else being equal.

爲了正確了解浙江潤陽新材料科技的盈利業績,我們需要考慮歸因於不尋常項目的420萬元人民幣支出。看到不尋常的項目使公司利潤損失從來都不是一件好事,但從好的方面來看,情況可能遲早會好轉。當我們分析全球絕大多數上市公司時,我們發現重大不尋常的事項往往不會重演。而且,畢竟,這正是會計術語的含義。假設這些不尋常的支出不會再次出現,因此,在其他條件相同的情況下,我們預計浙江潤陽新材料科技明年將實現更高的利潤。

Note: we always recommend investors check balance sheet strength. Click here to be taken to our balance sheet analysis of Zhejiang Runyang New Material Technology.

注意:我們始終建議投資者檢查資產負債表的實力。點擊此處查看我們對浙江潤陽新材料科技的資產負債表分析。

Our Take On Zhejiang Runyang New Material Technology's Profit Performance

我們對浙江潤陽新材料科技盈利表現的看法

Unusual items (expenses) detracted from Zhejiang Runyang New Material Technology's earnings over the last year, but we might see an improvement next year. Based on this observation, we consider it likely that Zhejiang Runyang New Material Technology's statutory profit actually understates its earnings potential! And the EPS is up 27% over the last twelve months. At the end of the day, it's essential to consider more than just the factors above, if you want to understand the company properly. In light of this, if you'd like to do more analysis on the company, it's vital to be informed of the risks involved. Case in point: We've spotted 2 warning signs for Zhejiang Runyang New Material Technology you should be aware of.

不尋常的項目(支出)減少了浙江潤陽新材料科技去年的收益,但明年我們可能會看到改善。基於這一觀察,我們認爲浙江潤陽新材料科技的法定利潤實際上可能低估了其盈利潛力!在過去的十二個月中,每股收益增長了27%。歸根結底,如果你想正確地了解公司,必須考慮的不僅僅是上述因素。有鑑於此,如果你想對公司進行更多分析,了解所涉及的風險至關重要。一個很好的例子:我們已經發現了兩個你應該注意的浙江潤陽新材料科技的警告信號。

This note has only looked at a single factor that sheds light on the nature of Zhejiang Runyang New Material Technology's profit. But there are plenty of other ways to inform your opinion of a company. Some people consider a high return on equity to be a good sign of a quality business. While it might take a little research on your behalf, you may find this free collection of companies boasting high return on equity, or this list of stocks that insiders are buying to be useful.

這份報告只研究了揭示浙江潤陽新材料科技利潤性質的單一因素。但是,還有很多其他方法可以讓你對公司的看法。有些人認爲高股本回報率是優質業務的好兆頭。雖然可能需要你進行一些研究,但你可能會發現這份免費收集的擁有高股本回報率的公司,或者這份內部人士正在購買的股票清單很有用。

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

對這篇文章有反饋嗎?對內容感到擔憂?直接聯繫我們。 或者,給編輯團隊 (at) simplywallst.com 發送電子郵件。
Simply Wall St的這篇文章本質上是籠統的。我們僅使用公正的方法根據歷史數據和分析師的預測提供評論,我們的文章無意作爲財務建議。它不構成買入或賣出任何股票的建議,也沒有考慮到您的目標或財務狀況。我們的目標是爲您提供由基本數據驅動的長期重點分析。請注意,我們的分析可能不考慮最新的價格敏感型公司公告或定性材料。簡而言之,華爾街沒有持有任何上述股票的頭寸。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論